TMIGD2 Antilichaam

TMIGD2 (transmembrane and immunoglobulin domain containing 1), also known as immunoglobulin-containing and proline-rich receptor 1 (IGPR1), is novel adhesion molecule that is expressed in multiple tissues, primarily in cells of epithelium and endothelium origins (1) . TMIGD2 is thought to be involved in angiogenesis and regulates cellular morphology, homophilic cell aggregation, and cell-cell interaction. TMIGD2 activity also modulates actin stress fiber formation and focal adhesion and reduces cell migration (1) .

126259

Q96BF3

NP_653216

Human

7617

Unconjugated

Primary Antibodies

Stem Cell

TMIGD2 antibody is Antigen-affinity purified.

Cat. No. 1408 - Mouse Small Intestine Tissue Lysate

1 mg/mL

TMIGD2 antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

TMIGD2 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year.

IgG

TMIGD2 antibody is human reactive. At least two isoforms of TMIGD2 are known to exist; this antibody will detect both isoforms. TMIGD2 antibody is predicted to not cross-react with TMIGD1.

TMIGD2

Cat. No. 11-801 - Human Small Intestine Tissue Slide

Transmembrane and immunoglobulin domain containing 2

Homo sapiens

Rahimi N et al. Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis. Mol. Biol. Cell 2012; 23:1646-56.

TMIGD2 Antibody: IGPR1, IGPR-1, IGPR1, UNQ3059/PRO9879, Transmembrane and immunoglobulin domain-containing protein 2, Immunoglobulin and proline-rich receptor 1

ELISA, WB, IHC-P

281306838

Liquid